Origene
1 known investors
OriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
BiotechHealthtech
Investors Β· 1
In the news
Frequently asked questions
- What does Origene do?
- OriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
- Who are Origene's investors?
- Origene's investors include Qiming Venture Partners.